Scarica l'app Stockscreener
72.08
0.24%
-0.17
Dopo l'orario di chiusura:
72.08
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Bio Techne Corp Borsa (TECH) Ultime notizie
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger – AUUD, TECH, CZR and CBAN - GlobeNewswire Inc.
TECH: Bio-Techne Corp Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Research Use Recombinant Protein Market Report Now Available — Forecasts Market Growth from $1.11B (2026) to $1.55B by 2031, Profiling Thermo Fisher, Bio-Techne, Merck KGaA, Danaher, Revvity, and Others - Yahoo Finance UK
Bio-Techne Corp (TECH) Stock Analysis: Navigating Its Current Valuation and Growth Potential - DirectorsTalk Interviews
Bio-Techne Corp (NASDAQ: TECH) Share Price, TECH Stock News, TECH Share Price & Updates - Kalkine
Ademi LLP investigates Bio-Techne sale to Merck KGaA - scanx.trade
Global Multiplex Assays Market 2026 Edition - GlobeNewswire Inc.
Bio-Techne Corp (TECH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - tradingkey.com
Bio-Techne (TECH), What Is Behind The Latest Attention? - simplywall.st
Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals - marketscreener.com
Legal & General buys $19.51M stake in Bio-Techne - Dealroom
Bio-Techne Corp (TECH) Stock Analysis: Evaluating the Balance Between Growth Potential and Current Valuation - DirectorsTalk Interviews
Winners And Losers Of Q2: Bio-Techne (NASDAQ:TECH) Vs The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance
Bio-Techne Corp (TECH) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Bio-Techne To Be Acquired by Merck KGaA - Morningstar
Bio-Techne draws fresh institutional cash as revenue climbs to $321M - app.dealroom.co
BIO-TECHNE Corp FY 2026: Revenue $1.22B, EPS $1.16— 10-K Summary - TradingView
Bio-Techne Gives FTC More Time On $11.3B Merck Deal - Law360
Is Bio-Rad a Buy as Digital PCR Growth Meets a Premium Valuation? - TradingView
Bio-Techne (Nasdaq: TECH) investors to vote on Merck cash takeover - Stock Titan
Bio-Techne (NASDAQ: TECH) GC gets new RSU grants, no stock sales - Stock Titan
Bio-Techne (NASDAQ: TECH) grants CFO 22,438 and 36,459 RSUs - Stock Titan
Bio-Techne (TECH) director granted 1,381 RSUs vesting 2027-29 - Stock Titan
Bio-Techne (TECH) insider updates stock holdings - Stock Titan
Bio-Techne (NASDAQ: TECH) grants president 8,702 and 14,140 RSUs - Stock Titan
Benchmark reiterates Hold stock rating on Bio-Techne after Q4 results - Investing.com India
BIO-TECHNE Executive Steven C. Crouse Files Form 4 After RSU Vesting and Share Withholding - Kalkine Media
Bio-Techne (TECH) CEO exercises awards, 10.8K shares withheld - Stock Titan
Bio-Techne (TECH) CFO exercises awards, covers taxes in stock - stocktitan.net
Bio-Techne (NASDAQ: TECH) exec updates option and RSU holdings - Stock Titan
Bio-Techne (TECH) GC sees RSUs vest, others forfeited on equity awards - Stock Titan
Bio-Techne (TECH) awards give executive 5,423 shares, 1,947 withheld - Stock Titan
Bio-Techne (TECH) director exercises 589 RSUs, uses shares for taxes - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Is Wall Street Bullish or Bearish on Bio-Techne Stock? - Yahoo Finance
Bio-Techne (TECH) Holds Steady at $72.39 as Shares Consolidate Between $68.77 Support and $76.01 ResistanceKey Reversal Day - vinanet.vn
Bio-Techne (TECH) Holds Steady at $72.40 as Life Sciences Sector Digests Mixed SignalsOption Strike Build - vinanet.vn
S&CO Inc. Buys Shares of 76,614 Bio-Techne Corp $TECH - MarketBeat
TECH Q2 2026 Earnings: EPS Misses Consensus, Shares Edge HigherMargin Guidance - vinanet.vn
TECH Q2 2026 Earnings: EPS Misses Consensus by 3.34% as Shares Edge HigherSaaS Earnings Trends - vinanet.vn
Bio-Techne Corp (TECH) Stock News Today - tradingkey.com
Wells Fargo Initiates Bio-Techne(TECH.US) With Hold Rating, Announces Target Price $73 - Moomoo
Bio-Techne's Fiscal Q4 Organic Revenue Growth Consistent With Progressive Improvement Story, RBC Says - marketscreener.com
Bio-Techne (NASDAQ:TECH) Downgraded to Equal Weight Rating by Wells Fargo & Company - MarketBeat
Bio-Techne (NASDAQ:TECH) Dividend Move Sparks Fresh Attention - Kalkine Media
TECH Q4 Earnings Meet Estimates, Revenues Surpass, Stock Rises - The Globe and Mail
Bio-Techne Keeps Quarterly Dividend at $0.08 a Share, Payable Aug. 28 to Shareholders of Record as of Aug. 24 - marketscreener.com
Bio-Techne Corp (NASDAQ:TECH) to Issue Dividend Increase$0.65 Per Share - MarketBeat
Bio-Techne Dividend Payable Aug. 28 After Record-Date Correction - Stock Titan
Bio-Techne Corp to Issue Quarterly Dividend of $0.08 (NASDAQ:TECH) - MarketBeat
Bio-Techne (NASDAQ:TECH) Releases Earnings Results, Meets Estimates - MarketBeat
Bio-Techne earnings matched, revenue topped estimates - Investing.com
Bio-Techne Announces Q4 and Full Fiscal Year 2026 Financial Results Alongside Cash Dividend Declaration - Kalkine Media
Bio-Techne Q4 Results: Sales rise 1.33% YoY, beat estimates - scanx.trade
Bio-Techne Releases Fourth Quarter Fiscal 2026 Results - investingnews.com
TECH Looks 1.1% Undervalued on GF Value™ Amid High P/E and Mixed Guru Activity - GuruFocus
Techne (TECH) Q4 Earnings Meet Estimates - Yahoo Finance
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):